Drug Abuse and Traffic

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from lawsuits related to Purdue Pharma.

Sacklers Threaten to Pull Out of Purdue Pharma Opioids Settlement

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad legal immunity.

States and Cities Near Tentative $26 Billion Deal in Opioids Cases

The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

McKinsey Issues a Rare Apology for Its Role in OxyContin Sales

The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.

McKinsey Issues a Rare Apology for Its Role in OxyContin Sales

The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.

McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses

Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.